Health begins at home

News
Article

Armed with a plethora of OTC test kits, consumers are taking do-it-yourself screenings to new heights

Recent Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
Related Content
FDA Approves Sulopenem Etzadroxil and Probenecid for Uncomplicated UTIs

FDA Approves Sulopenem Etzadroxil and Probenecid for Uncomplicated UTIs

Lauren Massaro
October 25th 2024
Article

The FDA has approved just the second treatment for uncomplicated urinary tract infections (UTIs) in the last 2 decades.

Looking to the Future of Independent Pharmacy

Looking to the Future of Independent Pharmacy

Miranda Hester
July 13th 2022
Podcast

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Gepotidacin NDA Under Priority Review by FDA for Uncomplicated UTI

Gepotidacin NDA Under Priority Review by FDA for Uncomplicated UTI

Lauren Biscaldi, MS, Managing Editor
October 16th 2024
Article

Gepotidacin is a first-in-class oral antibiotic with a novel mechanism of action.

Podcast: Pharmacy Financing With First Financial Bank

Podcast: Pharmacy Financing With First Financial Bank

January 28th 2022
Podcast

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

FDA Approves Ceftobiprole Medocaril Sodium for 3 Indications

FDA Approves Ceftobiprole Medocaril Sodium for 3 Indications

Jenny Zhao, PharmD;Kevin W. Chamberlin, PharmD, FASCP
October 14th 2024
Article

The FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.

FDA Roundup: Hemophilia B Therapy, Stelara Biosimilar Approval

FDA Roundup: Hemophilia B Therapy, Stelara Biosimilar Approval

Killian Meara
October 11th 2024
Article

Check out important updates from the FDA for the week of October 7.

© 2024 MJH Life Sciences

All rights reserved.